| Financial Year |
March 31 2023 |
| Monetary Funds |
140,667,226.70 |
| Held-for-trading Financial Assets |
32,909,300.00 |
| Notes Receivable |
159,677,795.60 |
| Accounts Receivable |
503,242,978.88 |
| Advances to Suppliers |
10,927,315.86 |
| Other Receivables |
30,239,749.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
197,785,899.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
136,357,879.72 |
| Total Current Assets |
1,225,004,933.75 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,477,906.69 |
| Investment Properties |
134,771,650.81 |
| Fixed Assetes |
238,927,479.70 |
| Under-construction Projects |
79,844,724.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,627,643.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,020,098.37 |
| Deferred Income Tax Assets |
14,144,251.13 |
| Other Non-Current Assets |
4,948,685.00 |
| Sub-Total of Non-Current Assets |
565,367,427.79 |
| Total Assets |
1,790,372,361.54 |
| Short-Term Loans |
457,676,599.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
57,169,769.77 |
| Accounts Received In Advance |
6,819,265.82 |
| Employee Compensation Payable |
14,534,789.09 |
| Taxes Payable |
7,800,073.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
54,544,767.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,529,761.90 |
| Other Current Liabilities |
97,208,136.65 |
| Sub-Total of Current Liabilities |
721,128,352.88 |
| Long-term Loans |
153,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,296,374.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
203,145,417.43 |
| Total Liabilities |
924,273,770.31 |
| Paid-In Capital(Or Share Stock) |
439,200,000.00 |
| Capital Surplus |
68,414,355.03 |
| Surplus Reserve |
17,724,532.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
215,737,575.81 |
| Minority Stockholder's Interest |
103,382,080.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
762,716,510.93 |
| Owner's Equity（Stockholder's Equity） |
866,098,591.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,790,372,361.54 |
